NYU Langone Health Update on Attention Deficit Hyperactivity Disorder Through the Lifespan 2024

Name: NYU Langone Health Update on Attention Deficit Hyperactivity Disorder Through the Lifespan 2024 - DrMedciene
SKU: MED-AMB-00862
Price: 20.00 USD
Availability: InStock

$20.00

This Product is shared via google drive download link, So please share your correct Gmail id while placing the order .Please note that there are no CME points or certificate associated with this course Samples for Courses Can be found here : Free Samples Here!

Include: 1 video + 8 pdfs, size: 7.97 GB

SKU: MED-AMB-00862 Category: Psychiatry Tag: Psychiatry

Description

NYU Langone Health Update on Attention Deficit Hyperactivity Disorder Through the Lifespan 2024

Include: 1 video + 8 pdfs, size: 7.97 GB

Target Audience: psychologists

Information:

Virtual Webinar New York, NY United States December 7, 2024 8:15 AM – 4:05 PM

This course will focus on the latest issues and important new findings in Attention Deficit Hyperactivity Disorder (ADHD) Through the Lifespan – in children, adolescents, and adults. This day-long, virtual course will feature a fantastic lineup of specialists in the field and a breakout “Ask the Experts” session where attendees can review clinical concerns with some of our expert panelists.

Topics for the day include: ADHD diagnosis and treatment in adults, adult ADHD guidelines and medication shortage issues, ADHD and depression, ADHD and cannabis use, ADHD and inflammation, and ADHD and learning disorders, among others.

Educational Objectives

After participating in this activity, clinicians should be able to:

Discuss identification and treatment of reading and learning disorders in children with these disorders and ADHD
Describe the high rates of overlap of substance use disorders and ADHD
Revise their screening protocols for ADHD for females of all ages as discussed in pending guidelines for adult ADHD
Screen their adult patients who have been diagnosed with depression for ADHD
Evaluate their current practice regarding the relative safety and efficacy of the pharmacological treatment of adults with ADHD
Discuss the most recent follow-up studies on persons with Long COVID investigating neurological, neuropsychological, and psychiatric symptoms relative to controls
Discuss the impact that parental ADHD has on coping with ADHD in children in the family

Target Audience

Physicians, Psychologists, Physician Assistants (PAs), Nurse Practitioners and Nurses

Topics:

Agenda.pdf
ADHD and Depression.pdf
ADHD Guidelines and Medication Shortage.pdf
ADHD, Substance Use Disorders and Cannabis Use.pdf
Implications of the Co-occurrence of ADHD and Specific Learning Disabilities.pdf
Keynote Address- Update on ADHD Diagnosis and Treatment Across the Lifespan.pdf
Parental ADHD and ADHD in the Family.pdf
The Possible Impact of Inflammation on ADHD Symptoms.pdf
Full Live.mp4 (7 hours 09 minutes)